CAG
LABD icon

Csenge Advisory Group’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Csenge Advisory Group’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,700
Closed -$271K – 743
2025
Q3 		$271K Buy
+6,700
New +$388K 0.01% 569

Other funds holding LABD

JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Csenge Advisory Group's LABD Position: Q4 2025 in Review

Csenge Advisory Group sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q4 2025, closing a stake of 6,700 shares — an estimated $271K sold.

Csenge Advisory Group first reported a position in LABD in Q3 2025 and held it in 1 quarter. The position peaked at $271K in Q3 2025. 17 funds tracked by Wall St. Rank hold LABD as of Q4 2025.

  • Csenge Advisory Group reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q4 2025 after selling out during the quarter.
  • Csenge Advisory Group sold 6,700 Direxion Daily S&P Biotech Bear 3X ETF shares in Q4 2025, an estimated $271K.
  • Csenge Advisory Group first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q3 2025 and held it in 1 quarter.
  • Csenge Advisory Group's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $271K in Q3 2025.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q4 2025.

Based on Csenge Advisory Group's 13F filing for Q4 2025, filed 6 Feb 2026.